Why Evogene Ltd. (EVGN) Soared on Monday

From Yahoo Finance: 2025-04-22 09:24:00

On Monday, the stock market closed in negative territory due to investor concerns over Trump’s tariff policies and Fed criticism. The Nasdaq fell 2.55%, Dow Jones 2.48%, and S&P 500 2.36%. However, 10 micro- to small-cap companies bucked the trend, with Evogene Ltd. (NASDAQ:EVGN) jumping 30.93% after selling a stake to ICL.

Evogene Ltd. (NASDAQ:EVGN) rose to $1.27 on Monday after agreeing to sell a controlling stake in Lavie Bio Ltd. to ICL. The acquisition includes MicroBoost AI for AG platform and is expected to be completed in Q2. ICL will gain Lavie Bio’s assets, strengthening its position in the ag-biologicals sector.

ICL’s acquisition of Lavie Bio assets, including its team, technology platform, and development programs, is expected to enhance the company’s position in the ag-biologicals sector. Lavie Bio focuses on microbiome-based products for agriculture sustainability and productivity, making EVGN a promising investment in the sector.

While EVGN ranks 9th among Monday’s top performers, AI stocks are seen as holding greater potential for higher returns within a shorter timeframe. Consider exploring other AI stocks with significant growth potential and lower valuation ratios compared to EVGN for potentially better investment opportunities in the sector.

For more insights and analysis on AI stocks, check out our report on the 20 Best AI Stocks to Buy Now and the 30 Best Stocks to Buy Now According to Billionaires. This article is originally published on Insider Monkey.

Read more: Why Evogene Ltd. (EVGN) Soared on Monday